+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Radiopharmaceutical Preclinical CRO Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 to 2032

  • PDF Icon

    Report

  • 117 Pages
  • November 2023
  • Region: Global
  • Acute Market Reports
  • ID: 5921749
Description Jump to:
The 'radiopharmaceutical preclinical CRO (Contract Research Organization) market' is a dynamic sector, integral to advancing preclinical research in the field of radiopharmaceuticals. The radiopharmaceutical preclinical CRO market is expected to grow at a CAGR of 8.5% during the forecast period of 2024 to 2032, driven by advancements in PET tracers research, the growing demand for oncology and neurology studies, and strategic collaborations among CROs. Challenges in therapeutic radiopharmaceutical development highlight the importance of seamless translational research. The segmentation by radiopharmaceutical type and therapeutic area provides a nuanced understanding of market dynamics, emphasizing the shift towards therapeutic applications and the rising significance of neurology research. The geographic segmentation underscores global trends and the pivotal role of regions like Asia-Pacific in shaping the future of preclinical radiopharmaceutical research.

Advancements in PET Tracers Research

The radiopharmaceutical preclinical CRO market experiences a significant boost from the ongoing advancements in PET (Positron Emission Tomography) tracers research. Evidence suggests that leading CROs, such as Covance and Charles River Laboratories, have actively contributed to the development of novel PET tracers for various preclinical studies. The increased sensitivity and precision offered by PET tracers enable more accurate imaging and analysis in preclinical trials, facilitating a deeper understanding of disease mechanisms and therapeutic responses.

Growing Demand for Oncology Research

The growing demand for oncology research acts as a major driver for the radiopharmaceutical preclinical CRO market. Evidential data indicates that CROs, including Jubilant Biosys and Selcia, have witnessed a surge in preclinical studies focused on oncology. The oncology therapeutic area not only commands substantial revenue in 2024 but also exhibits the highest expected CAGR during the forecast period from 2024 to 2032. This driver underscores the pivotal role of CROs in supporting advancements in cancer research, contributing to the development of innovative radiopharmaceuticals for diagnostic and therapeutic purposes.

Rising Interest in Neurology Studies

The rising interest in neurology studies emerges as another driver for the radiopharmaceutical preclinical CRO market. Evidence-based insights reveal that CROs, such as Pharmaron and WuXi AppTec, are actively engaged in preclinical research focusing on neurology. With advancements in imaging techniques and a growing understanding of neurodegenerative disorders, the neurology therapeutic area exhibits both substantial revenue and a high expected CAGR during the forecast period. This driver highlights the crucial role of CROs in supporting neuroscience research, paving the way for potential breakthroughs in the diagnosis and treatment of neurological conditions.

Challenges in Therapeutic Radiopharmaceutical Development

Despite the positive momentum, challenges in therapeutic radiopharmaceutical development pose a notable restraint. Evidence suggests occasional hurdles in the translation of preclinical findings to clinically viable therapeutic radiopharmaceuticals. CROs, including Eurofins DiscoverX and Nuvisan, actively address these challenges, emphasizing the need for seamless transitions from preclinical to clinical development. This restraint underscores the importance of collaborative efforts and a robust translational research framework to overcome barriers and expedite the clinical translation of preclinically validated radiopharmaceuticals.

Market Analysis by Radiopharmaceutical Type: PET Tracers Dominate the Market

Market segmentation by radiopharmaceutical type reveals dynamic trends in PET tracers, SPECT (Single Photon Emission Computed Tomography) tracers, and therapeutic radiopharmaceuticals. In 2024, PET tracers dominated the market, with the highest revenue and a significant contribution to the overall market share. However, the highest expected CAGR during the forecast period from 2024 to 2032 is in therapeutic radiopharmaceuticals. This segmentation underscores the evolving landscape of radiopharmaceutical preclinical research, with a notable shift toward therapeutic applications.

Market Analysis by Therapeutic Area: Oncology Segment Dominates the Market

The market segmentation by therapeutic area highlights the prominence of oncology, cardiology, neurology, and other areas in preclinical research. In 2024, oncology commands the highest revenue, driven by the increasing focus on cancer-related studies. Simultaneously, neurology emerges with the highest expected CAGR during the forecast period from 2024 to 2032, reflecting a growing emphasis on understanding and addressing neurological disorders. This segmentation provides insights into the diverse applications of radiopharmaceuticals in preclinical studies across multiple therapeutic areas.

North America Remains the Global Leader

The geographic segmentation of the radiopharmaceutical preclinical CRO market unveils global trends and regional variances. In 2024, North America led in terms of both revenue and market share, with CROs like Covance and Charles River Laboratories playing a significant role. However, Asia-Pacific is expected to exhibit the highest CAGR during the forecast period, driven by factors such as a growing focus on research and development in emerging economies and increasing collaborations with global pharmaceutical companies. This shift highlights the global nature of the market and the need for region-specific strategies to cater to diverse research landscapes.

Market Competition to Intensify during the Forecast Period

The competitive landscape of the radiopharmaceutical preclinical CRO market is characterized by strategic collaborations and a holistic market outlook. In 2024, CROs such as Covance, Charles River Laboratories, and Pharmaron dominated the market, reflecting their comprehensive capabilities and significant contributions to preclinical research. Strategies encompass collaborative ventures with pharmaceutical companies, expansion of service offerings, and investments in cutting-edge technologies. Looking ahead to the period from 2024 to 2032, these CROs are expected to continue their strategic initiatives, adapting to emerging market dynamics and contributing to the advancement of radiopharmaceutical research on a global scale.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. Key data points that enable the estimation of the Radiopharmaceutical Preclinical CRO market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value
  • Geographical revenues generated by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Radiopharmaceutical Preclinical CRO market and their expected impact during the forecast period
The market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

  • Service Type
  • Safety Assessment
  • Bioanalytical Testing
  • Dose Formulation
  • Regulatory Affairs Support
  • End-Use Industry
  • Pharmaceutical Companies
  • Biotechnology Firms
  • Academic Research Institutions
  • Government Organizations
  • Radiopharmaceutical Type
  • PET Tracers
  • SPECT Tracers
  • Therapeutic Radiopharmaceuticals
  • Therapeutic Area
  • Oncology
  • Cardiology
  • Neurology
  • Others
  • Organization Size
  • Small and Medium Enterprises (SMEs)
  • Large Pharmaceutical Corporations

Region Segment (2022-2032; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Radiopharmaceutical Preclinical CRO market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2032.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Radiopharmaceutical Preclinical CRO market?
  • Which is the largest regional market for Radiopharmaceutical Preclinical CRO market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Radiopharmaceutical Preclinical CRO market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Radiopharmaceutical Preclinical CRO market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Radiopharmaceutical Preclinical CRO Market
2.2. Global Radiopharmaceutical Preclinical CRO Market, By Service Type, 2023 (US$ Million)
2.3. Global Radiopharmaceutical Preclinical CRO Market, By End-Use Industry, 2023 (US$ Million)
2.4. Global Radiopharmaceutical Preclinical CRO Market, By Radiopharmaceutical Type, 2023 (US$ Million)
2.5. Global Radiopharmaceutical Preclinical CRO Market, By Therapeutic Area, 2023 (US$ Million)
2.6. Global Radiopharmaceutical Preclinical CRO Market, By Organization Size, 2023 (US$ Million)
2.7. Global Radiopharmaceutical Preclinical CRO Market, By Geography, 2023 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2023
3. Radiopharmaceutical Preclinical CRO Market: Competitive Analysis
3.1. Market Positioning of Key Radiopharmaceutical Preclinical CRO Market Vendors
3.2. Strategies Adopted by Radiopharmaceutical Preclinical CRO Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2031
4. Radiopharmaceutical Preclinical CRO Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Radiopharmaceutical Preclinical CRO Market Value, 2024-2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2031
5.3. Market Segmentation
5.3.1. Safety Assessment
5.3.2. Bioanalytical Testing
5.3.3. Dose Formulation
5.3.4. Regulatory Affairs Support
6. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2031
6.3. Market Segmentation
6.3.1. Pharmaceutical Companies
6.3.2. Biotechnology Firms
6.3.3. Academic Research Institutions
6.3.4. Government Organizations
7. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2031
7.3. Market Segmentation
7.3.1. PET Tracers
7.3.2. SPECT Tracers
7.3.3. Therapeutic Radiopharmaceuticals
8. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2023 Versus 2031
8.3. Market Segmentation
8.3.1. Oncology
8.3.2. Cardiology
8.3.3. Neurology
8.3.4. Others
9. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Growth & Revenue Analysis: 2023 Versus 2031
9.3. Market Segmentation
9.3.1. Small and Medium Enterprises (SMEs)
9.3.2. Large Pharmaceutical Corporations
10. North America Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
10.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
10.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
10.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
10.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
10.7. Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
10.7.1. North America
10.7.1.1. U.S.
10.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
10.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
10.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
10.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
10.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
10.7.1.2. Canada
10.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
10.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
10.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
10.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
10.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
10.7.1.3. Rest of North America
10.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
10.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
10.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
10.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
10.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
11. UK and European Union Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
11.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
11.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
11.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
11.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
11.7. Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
11.7.1. UK and European Union
11.7.1.1. UK
11.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
11.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
11.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
11.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
11.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
11.7.1.2. Germany
11.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
11.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
11.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
11.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
11.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
11.7.1.3. Spain
11.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
11.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
11.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
11.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
11.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
11.7.1.4. Italy
11.7.1.4.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
11.7.1.4.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
11.7.1.4.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
11.7.1.4.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
11.7.1.4.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
11.7.1.5. France
11.7.1.5.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
11.7.1.5.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
11.7.1.5.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
11.7.1.5.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
11.7.1.5.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
11.7.1.6. Rest of Europe
11.7.1.6.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
11.7.1.6.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
11.7.1.6.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
11.7.1.6.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
11.7.1.6.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
12. Asia Pacific Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
12.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
12.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
12.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
12.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
12.7. Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
12.7.1. Asia Pacific
12.7.1.1. China
12.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
12.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
12.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
12.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
12.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
12.7.1.2. Japan
12.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
12.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
12.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
12.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
12.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
12.7.1.3. India
12.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
12.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
12.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
12.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
12.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
12.7.1.4. Australia
12.7.1.4.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
12.7.1.4.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
12.7.1.4.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
12.7.1.4.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
12.7.1.4.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
12.7.1.5. South Korea
12.7.1.5.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
12.7.1.5.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
12.7.1.5.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
12.7.1.5.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
12.7.1.5.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
12.7.1.6. Rest of Asia Pacific
12.7.1.6.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
12.7.1.6.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
12.7.1.6.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
12.7.1.6.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
12.7.1.6.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
13. Latin America Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)
13.1. Market Overview
13.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
13.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
13.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
13.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
13.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
13.7. Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
13.7.1. Latin America
13.7.1.1. Brazil
13.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
13.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
13.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
13.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
13.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
13.7.1.2. Mexico
13.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
13.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
13.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
13.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
13.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
13.7.1.3. Rest of Latin America
13.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
13.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
13.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
13.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
13.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
14. Middle East and Africa Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)
14.1. Market Overview
14.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
14.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
14.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
14.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
14.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
14.7. Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
14.7.1. Middle East and Africa
14.7.1.1. GCC
14.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
14.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
14.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
14.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
14.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
14.7.1.2. Africa
14.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
14.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
14.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
14.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
14.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
14.7.1.3. Rest of Middle East and Africa
14.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
14.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
14.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
14.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
14.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
15. Company Profile
15.1. Charles River Laboratories International, Inc.
15.1.1. Company Overview
15.1.2. Financial Performance
15.1.3. Product Portfolio
15.1.4. Strategic Initiatives
15.2. Pharmaron Beijing Co., Ltd.
15.2.1. Company Overview
15.2.2. Financial Performance
15.2.3. Product Portfolio
15.2.4. Strategic Initiatives
15.3. Bioscan, Inc.
15.3.1. Company Overview
15.3.2. Financial Performance
15.3.3. Product Portfolio
15.3.4. Strategic Initiatives
15.4. Invicro (Konica Minolta)
15.4.1. Company Overview
15.4.2. Financial Performance
15.4.3. Product Portfolio
15.4.4. Strategic Initiatives
15.5. PerkinElmer, Inc.
15.5.1. Company Overview
15.5.2. Financial Performance
15.5.3. Product Portfolio
15.5.4. Strategic Initiatives
15.6. Siemens Healthineers
15.6.1. Company Overview
15.6.2. Financial Performance
15.6.3. Product Portfolio
15.6.4. Strategic Initiatives
15.7. IBA Radiopharma Solutions
15.7.1. Company Overview
15.7.2. Financial Performance
15.7.3. Product Portfolio
15.7.4. Strategic Initiatives
15.8. Covance, Inc. (Labcorp Drug Development)
15.8.1. Company Overview
15.8.2. Financial Performance
15.8.3. Product Portfolio
15.8.4. Strategic Initiatives
15.9. NorthStar Medical Radioisotopes, LLC
15.9.1. Company Overview
15.9.2. Financial Performance
15.9.3. Product Portfolio
15.9.4. Strategic Initiatives
15.10. PAREXEL International Corporation
15.10.1. Company Overview
15.10.2. Financial Performance
15.10.3. Product Portfolio
15.10.4. Strategic Initiatives
15.11. Eckert & Ziegler
15.11.1. Company Overview
15.11.2. Financial Performance
15.11.3. Product Portfolio
15.11.4. Strategic Initiatives
15.12. Jubilant Radiopharma
15.12.1. Company Overview
15.12.2. Financial Performance
15.12.3. Product Portfolio
15.12.4. Strategic Initiatives
15.13. Cardinal Health, Inc.
15.13.1. Company Overview
15.13.2. Financial Performance
15.13.3. Product Portfolio
15.13.4. Strategic Initiatives
15.14. Curium Pharma
15.14.1. Company Overview
15.14.2. Financial Performance
15.14.3. Product Portfolio
15.14.4. Strategic Initiatives
15.15. ImaginAb, Inc.
15.15.1. Company Overview
15.15.2. Financial Performance
15.15.3. Product Portfolio
15.15.4. Strategic Initiatives
15.16. Other Notable Players
15.16.1. Company Overview
15.16.2. Financial Performance
15.16.3. Product Portfolio
15.16.4. Strategic Initiatives
List of Figures
Figure 1 Global Radiopharmaceutical Preclinical CRO Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Radiopharmaceutical Preclinical CRO Market: Quality Assurance
Figure 5 Global Radiopharmaceutical Preclinical CRO Market, By Service Type, 2023
Figure 6 Global Radiopharmaceutical Preclinical CRO Market, By End-Use Industry, 2023
Figure 7 Global Radiopharmaceutical Preclinical CRO Market, By Radiopharmaceutical Type, 2023
Figure 8 Global Radiopharmaceutical Preclinical CRO Market, By Therapeutic Area, 2023
Figure 9 Global Radiopharmaceutical Preclinical CRO Market, By Organization Size, 2023
Figure 10 Global Radiopharmaceutical Preclinical CRO Market, By Geography, 2023
Figure 11 Market Geographical Opportunity Matrix - Global Radiopharmaceutical Preclinical CRO Market, 2023
Figure 12 Market Positioning of Key Radiopharmaceutical Preclinical CRO Market Players, 2023
Figure 13 Global Radiopharmaceutical Preclinical CRO Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2031
Figure 14 Global Radiopharmaceutical Preclinical CRO Market, By Service Type, 2023 Vs 2032, %
Figure 15 Global Radiopharmaceutical Preclinical CRO Market, By End-Use Industry, 2023 Vs 2032, %
Figure 16 Global Radiopharmaceutical Preclinical CRO Market, By Radiopharmaceutical Type, 2023 Vs 2032, %
Figure 17 Global Radiopharmaceutical Preclinical CRO Market, By Therapeutic Area, 2023 Vs 2032, %
Figure 18 Global Radiopharmaceutical Preclinical CRO Market, By Organization Size, 2023 Vs 2032, %
Figure 19 U.S. Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 20 Canada Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 21 Rest of North America Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 22 UK Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 23 Germany Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 24 Spain Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 25 Italy Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 26 France Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 27 Rest of Europe Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 28 China Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 29 Japan Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 30 India Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 31 Australia Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 32 South Korea Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 33 Rest of Asia Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 34 Brazil Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 35 Mexico Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 36 Rest of Latin America Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 37 GCC Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 38 Africa Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
Figure 39 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022-2032
List of Tables
Table 1 Global Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 2 Global Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 3 Global Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 4 Global Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 5 Global Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 6 North America Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 7 North America Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 8 North America Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 9 North America Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 10 North America Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 11 U.S. Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 12 U.S. Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 13 U.S. Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 14 U.S. Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 15 U.S. Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 16 Canada Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 17 Canada Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 18 Canada Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 19 Canada Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 20 Canada Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 21 Rest of North America Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 22 Rest of North America Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 23 Rest of North America Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 24 Rest of North America Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 25 Rest of North America Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 26 UK and European Union Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 27 UK and European Union Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 28 UK and European Union Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 29 UK and European Union Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 30 UK and European Union Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 31 UK Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 32 UK Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 33 UK Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 34 UK Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 35 UK Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 36 Germany Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 37 Germany Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 38 Germany Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 39 Germany Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 40 Germany Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 41 Spain Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 42 Spain Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 43 Spain Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 44 Spain Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 45 Spain Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 46 Italy Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 47 Italy Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 48 Italy Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 49 Italy Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 50 Italy Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 51 France Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 52 France Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 53 France Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 54 France Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 55 France Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 56 Rest of Europe Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 57 Rest of Europe Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 58 Rest of Europe Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 59 Rest of Europe Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 60 Rest of Europe Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 61 Asia Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 62 Asia Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 63 Asia Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 64 Asia Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 65 Asia Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 66 China Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 67 China Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 68 China Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 69 China Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 70 China Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 71 Japan Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 72 Japan Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 73 Japan Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 74 Japan Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 75 Japan Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 76 India Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 77 India Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 78 India Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 79 India Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 80 India Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 81 Australia Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 82 Australia Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 83 Australia Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 84 Australia Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 85 Australia Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 86 South Korea Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 87 South Korea Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 88 South Korea Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 89 South Korea Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 90 South Korea Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 91 Latin America Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 92 Latin America Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 93 Latin America Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 94 Latin America Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 95 Latin America Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 96 Brazil Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 97 Brazil Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 98 Brazil Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 99 Brazil Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 100 Brazil Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 101 Mexico Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 102 Mexico Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 103 Mexico Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 104 Mexico Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 105 Mexico Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 106 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 107 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 108 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 109 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 110 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 111 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 112 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 113 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 114 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 115 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 116 GCC Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 117 GCC Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 118 GCC Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 119 GCC Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 120 GCC Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 121 Africa Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 122 Africa Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 123 Africa Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 124 Africa Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 125 Africa Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
Table 126 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
Table 127 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
Table 128 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
Table 129 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
Table 130 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)

Companies Mentioned

  • Charles River Laboratories International, Inc.
  • Pharmaron Beijing Co., Ltd.
  • Bioscan, Inc.
  • Invicro (Konica Minolta)
  • PerkinElmer, Inc.
  • Siemens Healthineers
  • IBA Radiopharma Solutions
  • Covance, Inc. (Labcorp Drug Development)
  • NorthStar Medical Radioisotopes, LLC
  • PAREXEL International Corporation
  • Eckert & Ziegler
  • Jubilant Radiopharma
  • Cardinal Health, Inc.
  • Curium Pharma
  • ImaginAb, Inc.

Related Topics

Related Reports

Global Radiopharmaceuticals Market by Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), Procedural Volume (Diagnostic Procedures, Therapeutic Procedures), Application - Forecast 2023-2030 - Product Image

Global Radiopharmaceuticals Market by Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), Procedural Volume (Diagnostic Procedures, Therapeutic Procedures), Application - Forecast 2023-2030

  • Report
  • 180 Pages
  • Global
From
Radiopharmaceutical Theranostics Global Market Report 2024 - Product Image

Radiopharmaceutical Theranostics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Radiopharmaceutical Theranostics Market Report and Forecast 2023-2031 - Product Image

Global Radiopharmaceutical Theranostics Market Report and Forecast 2023-2031

  • Report
  • 140 Pages
  • Global
From
Radiopharmaceuticals Market Report by Product Type, Application, End Use, and Region 2023-2028 - Product Image

Radiopharmaceuticals Market Report by Product Type, Application, End Use, and Region 2023-2028

  • Report
  • 140 Pages
  • Global
From
Nuclear Medicine Market / Radiopharmaceuticals Market by Type (Diagnostic (SPECT-Technetium, PET-F-18), Therapeutic (Beta Emitters-Y-90, Alpha Emitters, Brachytherapy), Application (Neurology,Thyroid, Oncology), Procedures, End User - Global Forecast to 2028 - Product Image

Nuclear Medicine Market / Radiopharmaceuticals Market by Type (Diagnostic (SPECT-Technetium, PET-F-18), Therapeutic (Beta Emitters-Y-90, Alpha Emitters, Brachytherapy), Application (Neurology,Thyroid, Oncology), Procedures, End User - Global Forecast to 2028

  • Report
  • 342 Pages
  • Global
From

About the Market

Within the biopharmaceutical industry, which encompasses a diverse range of products including vaccines, blood components, gene therapies, and drugs derived from biological sources, the radiopharmaceutical preclinical contract research organization (CRO) market is a specialized segment. Radiopharmaceuticals are medicinal formulations that contain radioisotopes and are used in the field of nuclear medicine for both diagnosis and treatment of diseases. Preclinical CROs in this market offer outsourced research services that specifically cater to the early development needs of new radiopharmaceuticals. These services include, but are not limited to, pharmacokinetic and pharmacodynamic studies, toxicity testing, and regulatory support, all using radioactive compounds. The collaborations help in optimizing the development pathway for radiopharmaceuticals by providing specialized expertise, reducing research duration, and managing resources efficiently. Given the intricate safety and regulatory considerations of radiopharmaceuticals, CROs often operate in highly controlled environments with sophisticated equipment to track the distribution and decay of radioactive materials within biological systems. Some companies that are active in the radiopharmaceutical preclinical CRO market include: Covance (part of LabCorp), Charles River Laboratories, WuXi AppTec, Pharmaron, ICON plc, and Medpace. These organizations aid in advancing new radiopharmaceuticals from the laboratory bench to the threshold of clinical trials, facilitating their eventual entry into the market for clinical use. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.